Intracoronary stenting without coumadin: One month results of a French multicenter study
Catheterization and Cardiovascular Diagnosis · 1995-05 · 35 (1) · 1-7
DOI: 10.1002/ccd.1810350102 ↗Abstract
Abstract In order to simplify post‐coronary stenting treatment and to obtain a lower rate of complications, especially in bailout situations, seven French institutions treated 246 stented patients with 0.25 g/day of ticlopidine, 0.1 g/day of IV aspirin, and 2 days of heparin followed by low‐molecular‐weight heparin for 1 month. Fifty percent of patients had a planned stenting procedure, and 50% had an unplanned procedure, including 29 (11.8%) in bailout situations. Subacute occlusion occurred in three (1.2%) patients (one death, two non‐Q‐wave infarctions). During the 1 month follow‐up period, another death was reported (non‐stent‐related), two elective coronary artery bypass grafts were performed, and three additional patients presented with non‐Q‐wave myocardial infarctions. Nine (3.7%) patients had a groin complication that required blood transfusion or surgical repair. These results suggest that while waiting for the technological advancements of stents, postprocedural treatment that includes a low dosage of ticlopidine, aspirin, and low‐molecular‐weight heparin is a very effective alternative to conventional poststenting therapy. © 1995 Wiley‐Liss, Inc.
EUVIMED